SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-19-014252
Filing Date
2019-08-01
Accepted
2019-07-31 21:51:51
Documents
2
Period of Report
2019-07-31
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k073119_delmarpharma.htm 8-K 21516
2 LETTER FROM ERNST & YOUNG LLP TO THE U.S. SECURITIES AND EXCHANGE COMMISSION, DA f8k073119ex16-1_delmar.htm EX-16.1 2347
  Complete submission text file 0001213900-19-014252.txt   25072
Mailing Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720-999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (604) 629-5989
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-37823 | Film No.: 19990680
SIC: 2834 Pharmaceutical Preparations